Atlas Trials

A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Clinical trial NCT05012436 · COMPLETED

Trial details

NCT number
NCT05012436
Sponsor
Yuhan Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteerRenal Impairments
Start date
2021-07-24
Primary completion
2022-05-10
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.